REGENERX BIOPHARMACEUTICALS INC (RGN) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 74 transactions totaling $29.7M, demonstrating a bullish sentiment with $28.5M in net insider flow. The most recent transaction on Dec 7, 2010 involved a transaction of 20,000 shares valued at $0.
No significant insider buying has been recorded for RGN in the recent period.
No significant insider selling has been recorded for RGN in the recent period.
Based on recent SEC filings, insider sentiment for RGN is bullish with an Insider Alignment Score of 98/100 and a net flow of $28.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at REGENERX BIOPHARMACEUTICALS INC (RGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading RGN stock, having executed 74 transactions in the past 90 days. The most active insider is Paolo Cavazza (Executive), who has made 12 transactions totaling $11.7M.
Get notified when executives and directors at RGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 7, 2010 | L. Goldstein Allan | Executive | Gift | 20,000 | $N/A | $0 | |
| Sep 15, 2010 | L. Goldstein Allan | Executive | Gift | 30,000 | $N/A | $0 | |
| Jun 11, 2010 | Neil Lyons C. | Executive | Purchase | 15,000 | $0.28 | $4.2K | |
| Jun 10, 2010 | Neil Lyons C. | Executive | Purchase | 5,000 | $0.28 | $1.4K | |
| May 21, 2010 | Cavazza Paolo | Executive | Purchase | 240,000 | $N/A | $0 | |
| Feb 2, 2010 | J. Finkelstein J. | Executive | Gift | 500 | $N/A | $0 | |
| Jan 4, 2010 | L. Goldstein Allan | Executive | Gift | 50,000 | $N/A | $0 | |
| Jan 4, 2010 | L. Goldstein Allan | Executive | Gift | 50,000 | $N/A | $0 | |
| Dec 17, 2009 | L. Goldstein Allan | Executive | Gift | 2,000 | $N/A | $0 | |
| Oct 20, 2009 | J. Finkelstein J. | Executive | Gift | 12,500 | $N/A | $0 | |
| Oct 20, 2009 | J. Finkelstein J. | Executive | Gift | 12,500 | $N/A | $0 | |
| Oct 20, 2009 | J. Finkelstein J. | Executive | Gift | 12,500 | $N/A | $0 | |
| Oct 8, 2009 | &. Servicos Sdc Unipessoal Lda Chaumiere Consultadoria | Executive | Purchase | 1,219,512 | $0.82 | $1000.0K | Large |
| Oct 8, 2009 | Cavazza Paolo | Executive | Purchase | 1,219,512 | $0.82 | $1000.0K | Large |
| Aug 5, 2009 | L. Goldstein Allan | Executive | Gift | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 32 | $29.1M | 94.0% |
Exercise (Options)(X) | 3 | $1.2M | 3.8% |
Sale(S) | 2 | $600.0K | 1.9% |
Exercise(M) | 3 | $58.6K | 0.2% |
Award(A) | 1 | $19.6K | 0.1% |
Gift(G) | 33 | $0 | 0.0% |
Insiders at REGENERX BIOPHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 10 insiders making 74 transactions totaling $29.1M in purchases versus $600.0K in sales, the net buying activity of $28.5M signals strong executive confidence. Paolo Cavazza (Executive) leads the buying activity with $11.7M in transactions across all time.